XBiotech Inc. (XBIT)

Name: XBiotech Inc. (XBIT) Share Price Today, Stock Analysis, Annual Report | Value Research
Brand: XBiotech Inc. (XBIT)

Stock Card

$2.27

$-0.03 (-1.30%)

As on 28-Aug-2026 16:00EDT

Market cap

$69 Mln

Revenue (TTM)

$0 Mln

P/E Ratio

P/B Ratio

0.5

Div. Yield

0 %

Value Research Rating

Quality Score

Growth Score

Valuation Score

Momentum Score

Know more

Explore 5 star rated stocks

XBiotech (XBIT) Share Price

Compare

High: Low: Return:

Price P/E Ratio P/B Ratio

Stock Range

Today’s Range

Low: 2.26 High: 2.32

52 Week Range

Low: 2.09 High: 3.55

Liquidity

Low Moderate High

Fundamentals

Net Profit (TTM)

$0 Mln
ROE

-0.3 %
ROCE

-- %
Industry P/E

--
EV/EBITDA

-1.6
Debt to Equity

0
Book Value

$4.2
EPS

$-1.5
Face value

--
Shares outstanding

30,487,731

10 Years Aggregate

CFO

$-188.73 Mln

EBITDA

$-295.23 Mln

Net Profit

$416.28 Mln

Company	YTD	1 Month	3 Months	1 Year	3 Years	5 Years	10 Years
XBiotech (XBIT)	-5.0	0.4	-7.0	-34.8	-26.3	-32.4	-16.1
BSE Sensex^*	-9.1	-1.2	2.9	-3.6	5.7	6.2	10.5

As on 28-Aug-2026 | *As on 31-Aug-2026

Company	2025	2023	2022	2021	2020	2019
XBiotech (XBIT)	-39.5	14.0	-68.5	-28.9	-16.2	267.4
BSE Sensex	9.1	18.7	4.4	22.0	15.8	14.4
BSE Sensex	9.1	18.7	4.4	22.0	15.8	14.4

Essential Checks

View Details

Is there a threat to the company's solvency?

Can creative accounting be detected through the financial numbers?

How did the company perform in the last one year?

Financials

View Details

Key Ratios

View Details

Shareholding Pattern

View Details

About XBiotech (XBIT)

XBiotech Inc., a biopharmaceutical company, discovers, and develops, True Human monoclonal antibodies for treating various diseases. It develops a pipeline of product candidates targeting inflammatory and infectious diseases. The company is also... developing interleukin-1 alpha therapies to various medical conditions, such as cancer, stroke, heart attack, or arthritis; and mediates tissue breakdown, angiogenesis, the formation of blood clots, malaise, muscle wasting, and general inflammation. The company was incorporated in 2005 and is headquartered in Austin, Texas. Read more

Founder, President, CEO & Chairman

Mr. John Simard
Founder, President, CEO & Chairman

Mr. John Simard
Headquarters

Austin, TX
Website

https://www.xbiotech.com

FAQs for XBiotech (XBIT)

What is the current share price of XBiotech Inc (XBIT) Today?

The share price of XBiotech Inc (XBIT) is $2.27 (NASDAQ) as of 28-Aug-2026 16:00 EDT. XBiotech Inc (XBIT) has given a return of -26.25% in the last 3 years.

What is the current PB & PE ratio of XBiotech Inc (XBIT)?

Since, TTM earnings of XBiotech Inc (XBIT) is negative, P/E ratio is not available.
The P/B ratio of XBiotech Inc (XBIT) is 0.55 times as on 28-Aug-2026, a 89 discount to its peers’ median range of 4.83 times.

PE & PB ratio at the end of financial year.